Search

671. Facility-initiated discharges in nursing homes require further attention

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, November 2021

Subject(s):

Government Regulation
Nursing Homes -- legislation & jurisprudence
Patient Advocacy -- statistics & numerical data
Patient Discharge -- economics
United States
United States. Department of Health and Human Services

672. States’ backlogs of standard surveys of nursing homes grew substantially during the COVID-19 pandemic

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2021

Subject(s):

Government Regulation
Health Care Surveys -- statistics & numerical data
Nursing Homes -- legislation & jurisprudence
COVID-19
United States
United States. Department of Health and Human Services

673. SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2021

Subject(s):

United States Substance Abuse and Mental Health Services Administration
Buprenorphine -- supply & distribution
Government Regulation
Opioid Epidemic
United States
United States. Department of Health and Human Services

674. High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021

Subject(s):

Drug Development -- legislation & jurisprudence
Government Regulation
Medicare Part B -- economics
Medicare Part D -- economics
Orphan Drug Production -- economics
United States
United States. Department of Health and Human Services

675. HHS roadmap for behavioral health integration

Author(s):

Dey, Judith, author
Jacobus-Kantor, Laura, author
Stoller, Bethany, author
West, Kristina D., author
Blanco, Martin, (Of Office of Behavioral Health, Disability, and Aging Policy, HHS Office of the Assistant Secretary for Planning and Evaluation), author
Creedon, Timothy B., author
Nye, Emma, author
Ali, Mir M., (Health economist) author
Dubenitz, Joel M., author
Schwartz, Daniel, (Of Office of Behavioral Health, Disability, and Aging Policy, HHS Office of the Assistant Secretary for Planning and Evaluation), author
Bagalman, Erin, author
Kennedy, Gavin, (Of Office of Behavioral Health, Disability, and Aging Policy, HHS Office of the Assistant Secretary for Planning and Evaluation), author
Sherry, Tisamarie, author
Radel, Laura, author
Schreier, Alayna, author
Oberlander, Sara, author
Burnszynski, Jennifer, author
Lynch-Smith, Miranda, author
White, Jessica O., author
Bush, Laina, author
Swenson-O’Brien, Alicia J., author
Rousseau, Monica, author
Haffajee, Rebecca L., author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, September 2022

Subject(s):

Behavioral Medicine
Delivery of Health Care, Integrated
Mental Health Services -- organization & administration
Health Equity
United States
United States. Department of Health and Human Services

676. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022

Subject(s):

Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services

677. Public health preparedness: HHS should address strategic national stockpile requirements and inventory risks : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, October 2022

Subject(s):

Civil Defense -- statistics & numerical data
Government Regulation
Legislation, Medical
Strategic Stockpile -- organization & administration
United States
United States. Department of Health and Human Services

678. Tracking the funds: specific fiscal year 2022 provisions for Department of Health and Human Services : report to congressional committees

Publication:

[Washington, DC] : United States Government Accountability Office, October 2022

Subject(s):

Financing, Government -- organization & administration
Financing, Government -- standards
Government Regulation
Legislation, Medical
United States
United States. Department of Health and Human Services

679. Medicare Advantage: Plans generally offered some supplemental benefits, but CMS has limited data on utilization : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, January 2023

Subject(s):

Government Regulation
Insurance, Medigap -- legislation & jurisprudence
Legislation, Medical
Medicare Part C -- statistics & numerical data
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

680. Review of personnel shortages in federal health care programs during the COVID-19 pandemic

Publication:

Washington, D.C. : Pandemic Response Accountability Committee, September 2023

Subject(s):

COVID-19 -- economics
Government Programs
Government Regulation
Health Workforce -- statistics & numerical data
United States
United States. Department of Defense
United States. Department of Health and Human Services
United States. Department of Justice
United States. Department of Veterans Affairs